Specialty drug price caps drastically reduce out-of-pocket costs without increasing health plan spending

CVS HealthHub rollout resumes.

” One of the positive findings here is that people we wished to assist were, in fact, assisted,” Stacie Dusetzina, PhD, one of the studys authors, informed STAT. “All other proposals out there might face less resistance amongst those who think this will increase health plan costs and premiums.”.

More short articles on pharmacy: CVS HealthHub rollout resumesMerck bets on one-shot vaccineCVS, Walgreens & & Costco demanded not filling opioid prescriptions.

The research study highlighted that health insurance costs for specialty drugs has actually soared from around 26 percent of overall drug costs to 49 percent in the past 10 years, although these medications make up less than 2.5 percent of prescriptions.

Katie Adams –
Tuesday, August 11th, 2020
Print|Email.

Delaware, Maryland and Louisiana passed laws that put $150 cost caps on patients out-of-pocket expenses for specialized prescriptions, such as those that treat numerous sclerosis and rheumatoid arthritis. These laws led to a 32 percent reduction in spending for patients in requirement of these drugs, however did not lead to any changes in health insurance costs per client.

States that implemented out-of-pocket rate caps for pricey specialty drugs saw client costs on these medications reduce $351 per month, according to new analysis published in the New England Journal of Medicine.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.